Genotoxicity of 5-aminolevulinic and 4,5-dioxovaleric acids in the salmonella/microsuspension mutagenicity assay and SOS chromotest.

Environ Mol Mutagen

Instituto de Química, Departamento de Bioquímica, Universidade de São Paulo, São Paulo, Brazil.

Published: September 2002

5-Aminolevulinic acid (ALA) is a heme precursor that accumulates in some porphyric disorders and in lead poisoning which can undergo metal-catalyzed oxidation producing reactive oxygen species and the keto-aldehyde, 4,5-dioxovaleric acid (DOVA). Evidence in vitro of ALA-induced DNA lesions suggests that ALA and DOVA have mutagenic potential that could possibly contribute to an increased frequency of hepatocellular carcinoma (HCC) in patients with acute intermittent porphyria (AIP). In this study, we evaluated the genotoxic potential of ALA and DOVA. In the absence of exogenous metabolic activation, ALA and DOVA were mutagenic in Salmonella typhimurium tester strain TA104. ALA was also mutagenic in S. typhimurium TA102, but not in TA98, TA100, or TA1535, indicating an oxidative mechanism. Removal of H(2)O(2) with catalase gave only partial protection, suggesting generation of other mutagenic species. Both ALA and DOVA damaged the DNA of Escherichia coli PQ37, inducing the SOS response detected by an increase in beta-galactosidase activity. These results verified the potential mutagenic activity of ALA and DOVA and reinforce the hypothesis that DNA damage induced by ALA may be associated with the development of HCC in individuals suffering from AIP.

Download full-text PDF

Source
http://dx.doi.org/10.1002/em.10083DOI Listing

Publication Analysis

Top Keywords

ala dova
20
ala
8
dova mutagenic
8
dova
6
mutagenic
5
genotoxicity 5-aminolevulinic
4
5-aminolevulinic 45-dioxovaleric
4
45-dioxovaleric acids
4
acids salmonella/microsuspension
4
salmonella/microsuspension mutagenicity
4

Similar Publications

Introduction: Acute intermittent porphyria (AIP) is a very rare (orphan) metabolic disorder of porphyrin biosynthesis which is characterized by elevated plasma and urine levels of 5-aminolevulinic acid (5-ALA) and porphobilinogen (PBG). Patients with this disorder which is caused by a germline mutation of the hydroxymethylbilan-synthase (HMBS)-gene have a high risk of primary liver cancer which may be determined by disease activity. The exact mechanism of carcinogenesis of this rare tumor is unknown, however.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the long-term effectiveness and safety of givosiran in treating acute hepatic porphyria, a condition characterized by toxic levels of heme precursors.
  • It involved an interim analysis of the ENVISION study, where patients either received givosiran or a placebo for six months, followed by an open-label extension.
  • Results showed that givosiran significantly reduced attack frequency, need for hemin treatment, and daily pain severity, while also improving patients' quality of life with an acceptable safety profile.
View Article and Find Full Text PDF

The dual face of endogenous alpha-aminoketones: pro-oxidizing metabolic weapons.

Comp Biochem Physiol C Toxicol Pharmacol

October 2007

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, 05508-900, São Paulo, SP, Brazil.

Amino metabolites with potential prooxidant properties, particularly alpha-aminocarbonyls, are the focus of this review. Among them we emphasize 5-aminolevulinic acid (a heme precursor formed from succinyl-CoA and glycine), aminoacetone (a threonine and glycine metabolite), and hexosamines and hexosimines, formed by Schiff condensation of hexoses with basic amino acid residues of proteins. All these metabolites were shown, in vitro, to undergo enolization and subsequent aerobic oxidation, yielding oxyradicals and highly cyto- and genotoxic alpha-oxoaldehydes.

View Article and Find Full Text PDF

5-Aminolevulinate and 4, 5-dioxovalerate ions decrease GABA(A) receptor density in neuronal cells, synaptosomes and rat brain.

Brain Res

June 2006

Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Av. Prof. Lineu Prestes 748, 05508-900 São Paulo, SP, Brazil.

Porphyrias are heme-associated metabolic disorders such as intermittent acute porphyria (IAP) and lead poisoning, where 5-aminolevulinate (ALA) accumulates. Effects of ALA on the CNS have been explained by ALA binding to GABA(A) receptors, followed by receptor lesions from oxyradicals and 4, 5-dioxovalerate (DOVA) generated from metal-catalyzed ALA oxidation by oxygen. We have characterized the effects of ALA and DOVA on GABA(A) receptor density in synaptosomes and neurons in vitro and also in brains of rats treated with ALA or succinylacetone methyl ester (SAME), a tyrosine catabolite derivative able to induce ALA accumulation.

View Article and Find Full Text PDF

5-Aminolevulinic acid synthesis in epimastigotes of Trypanosoma cruzi.

Int J Biochem Cell Biol

August 2003

Centro de Investigaciones sobre Porfirinas y Porfirias-CIPYP (CONICET-FCEN, UBA), Ciudad Universitaria Pabellón II 2do, Piso, 1428 Buenos Aires, Argentina.

Background And Aims: Trypanosoma cruzi is the causative agent of Chagas disease or American trypanosomiasis. The parasite manifests a nutritional requirement for heme compounds because of its biosynthesis deficiency. The aim of this study has been to investigate the presence of metabolites and enzymes of porphyrin pathway, as well as ALA formation in epimastigotes of T.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!